Pacira BioSciences, Inc.

NasdaqGS:PCRX

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

💊 Drugstores & Retail Pharmacies

💊 Pharmaceuticals

💻 Telehealth

Location

United States

Market Cap

USD 1.04 B

Share Price

USD 22.55

Avg Daily Volume

758,848

Change (1 day)

3.35%

Change (1 year)

12.86%

Change (YTD)

19.69%

Pacira BioSciences, Inc. Operating Income Margin for the Trailing 12 Months (TTM) ending March 31, 2025: -11.65%

Pacira BioSciences, Inc. Operating Income Margin is -11.65% for the Trailing 12 Months (TTM) ending March 31, 2025, a -174.44% change year over year. Operating Income Ratio is the proportion of a company's operating income to its net sales, measuring the efficiency of its core business operations in generating profits.

Pacira BioSciences, Inc. Operating Income Margin for the Trailing 12 Months (TTM) ending March 31, 2024 was 15.65%, a 98.79% change year over year.
Pacira BioSciences, Inc. Operating Income Margin for the Trailing 12 Months (TTM) ending March 31, 2023 was 7.87%, a -48.00% change year over year.
Pacira BioSciences, Inc. Operating Income Margin for the Trailing 12 Months (TTM) ending March 31, 2022 was 15.14%, a 36.97% change year over year.
Pacira BioSciences, Inc. Operating Income Margin for the Trailing 12 Months (TTM) ending March 31, 2021 was 11.05%, a 81.63% change year over year.